Cite

HARVARD Citation

    Coutsouvelis, J. et al. (n.d.). Effectiveness of a single fixed dose of rasburicase 3 mg in the management of tumour lysis syndrome. British journal of clinical pharmacology. pp. 565-568. [Online]. 
  
Back to record